التفاصيل البيبلوغرافية
| العنوان: |
Composite diffuse large B-cell and peripheral T-cell lymphoma with T-helper phenotype treated with both rituximab and brentuximab vedotin. |
| المؤلفون: |
Ohya, Kouichi, Okuyama, Shuhei, Ogata, Shin-ya, Maeda, Kunihiko, Yamada, Kyohei, Ohshima, Kouichi, Tajima, Katsushi |
| المصدر: |
Annals of Hematology; Nov2021, Vol. 100 Issue 11, p2873-2875, 3p |
| مصطلحات موضوعية: |
T-cell lymphoma, PHENOTYPES, RITUXIMAB, FOLLICULAR dendritic cells, HEMATOXYLIN & eosin staining |
| مستخلص: |
We diagnosed CL comprising diffuse large B-cell lymphoma (DLBCL) and nodal peripheral T-cell lymphoma with T-follicular helper phenotype (PTCL-TFH), according to the revised 2017 World Health Organization (WHO) classification [[3]]. Dear Editor, Composite lymphoma (CL) is defined as two or more distinct lymphoma subtypes in a single anatomic tissue or the same lymph node, while discordant lymphoma is two or more distinct lymphoma subtypes existing at different sites simultaneously [[1]]. [Extracted from the article] |
|
Copyright of Annals of Hematology is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
